Warning: The NCBI web site requires JavaScript to function. more...
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines.
Zabouo G, Imbert AM, Jacquemier J, Finetti P, Moreau T, Esterni B, Birnbaum D, Bertucci F, Chabannon C.
Breast Cancer Res. 2009;11(1):R1. Epub 2009 Jan 5.
Related citations
JAM-A expression positively correlates with poor prognosis in breast cancer patients.
McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM, Gallagher WM.
Int J Cancer. 2009 Sep 15;125(6):1343-51.
Nm23-H1 suppresses tumor cell motility by down-regulating the lysophosphatidic acid receptor EDG2.
Horak CE, Lee JH, Elkahloun AG, Boissan M, Dumont S, Maga TK, Arnaud-Dabernat S, Palmieri D, Stetler-Stevenson WG, Lacombe ML, Meltzer PS, Steeg PS.
Cancer Res. 2007 Aug 1;67(15):7238-46.
Differential gene expression in breast cancer cell lines and stroma-tumor differences in microdissected breast cancer biopsies revealed by display array analysis.
Mellick AS, Day CJ, Weinstein SR, Griffiths LR, Morrison NA.
Int J Cancer. 2002 Jul 10;100(2):172-80.
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays.
Rodenhiser DI, Andrews J, Kennette W, Sadikovic B, Mendlowitz A, Tuck AB, Chambers AF.
Breast Cancer Res. 2008;10(4):R62. Epub 2008 Jul 18.
Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
Cai D, Cao J, Li Z, Zheng X, Yao Y, Li W, Yuan Z.
BMC Cancer. 2009 Apr 1;9:102.
Isolation and characterization of the major form of human MUC18 cDNA gene and correlation of MUC18 over-expression in prostate cancer cell lines and tissues with malignant progression.
Wu GJ, Wu MW, Wang SW, Liu Z, Qu P, Peng Q, Yang H, Varma VA, Sun QC, Petros JA, Lim SD, Amin MB.
Gene. 2001 Nov 14;279(1):17-31.
Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data.
Grigoriadis A, Mackay A, Reis-Filho JS, Steele D, Iseli C, Stevenson BJ, Jongeneel CV, Valgeirsson H, Fenwick K, Iravani M, Leao M, Simpson AJ, Strausberg RL, Jat PS, Ashworth A, Neville AM, O'Hare MJ.
Breast Cancer Res. 2006;8(5):R56.
Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer.
Chang XZ, Li DQ, Hou YF, Wu J, Lu JS, Di GH, Jin W, Ou ZL, Shen ZZ, Shao ZM.
Breast Cancer Res. 2007;9(6):R76.
Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A, Fillmore RA, Metge BJ, Rajesh M, Xi Y, King J, Ju J, Pannell L, Shevde LA, Samant RS.
Breast Cancer Res. 2008;10(2):R22. Epub 2008 Mar 7.
Genetic manipulation of stromal cell-derived factor-1 attests the pivotal role of the autocrine SDF-1-CXCR4 pathway in the aggressiveness of breast cancer cells.
Kang H, Mansel RE, Jiang WG.
Int J Oncol. 2005 May;26(5):1429-34.
The expression of the von Hippel-Lindau gene product and its impact on invasiveness of human breast cancer cells.
Zia MK, Rmali KA, Watkins G, Mansel RE, Jiang WG.
Int J Mol Med. 2007 Oct;20(4):605-11.
[Identification of the differentially expressed genes between primary breast cancer and paired lymph node metastasis through combining mRNA differential display and gene microarray].
Feng YM, Gao G, Zhang F, Chen H, Wan YF, Li XQ.
Zhonghua Yi Xue Za Zhi. 2006 Oct 24;86(39):2749-55. Chinese.
Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J.
Clin Cancer Res. 2005 Jun 15;11(12):4357-64.
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines.
Roll JD, Rivenbark AG, Jones WD, Coleman WB.
Mol Cancer. 2008 Jan 25;7:15.
Gene expression profiling of the tumor microenvironment during breast cancer progression.
Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC.
Breast Cancer Res. 2009;11(1):R7. Epub 2009 Feb 2.
Overexpression of endoplasmic reticulum protein 29 regulates mesenchymal-epithelial transition and suppresses xenograft tumor growth of invasive breast cancer cells.
Bambang IF, Xu S, Zhou J, Salto-Tellez M, Sethi SK, Zhang D.
Lab Invest. 2009 Nov;89(11):1229-42. Epub 2009 Sep 21.
ShRNA-mediated gene silencing of MTA1 influenced on protein expression of ER alpha, MMP-9, CyclinD1 and invasiveness, proliferation in breast cancer cell lines MDA-MB-231 and MCF-7 in vitro.
Jiang Q, Zhang H, Zhang P.
J Exp Clin Cancer Res. 2011 May 19;30:60.
Overexpression of caveolin-1 and -2 in cell lines and in human samples of inflammatory breast cancer.
Van den Eynden GG, Van Laere SJ, Van der Auwera I, Merajver SD, Van Marck EA, van Dam P, Vermeulen PB, Dirix LY, van Golen KL.
Breast Cancer Res Treat. 2006 Feb;95(3):219-28. Epub 2005 Oct 22.
Molecular profiling of breast cancer cell lines defines relevant tumor models and provides a resource for cancer gene discovery.
Kao J, Salari K, Bocanegra M, Choi YL, Girard L, Gandhi J, Kwei KA, Hernandez-Boussard T, Wang P, Gazdar AF, Minna JD, Pollack JR.
PLoS One. 2009 Jul 3;4(7):e6146.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on